Baxter’s multiple-dose vial Heparin causing allergy
Baxter’s Multiple-dose Vial Heparin Linked to Severe Allergic Reactions. FDA advises health care practitioners to switch suppliers and limit use of drug until problem identified. – The U.S. Food and Drug Administration announced today that Baxter Healthcare Corporation has temporarily stopped manufacturing multiple-dose vials of the injectable blood-thinning drug heparin due to reports of serious allergic reactions and hypotension (low blood pressure) in patients who receive high “bolus” doses of the drug.